Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Noven Resolves FDA Warning Letter

By Noven Pharmaceuticals, Inc. | April 25, 2018

Noven Pharmaceuticalshas received a close-out letter from the FDA lifting a 2016 Warning Letter related to its Miami, Florida manufacturing facility. The FDA notice follows a reinspection earlier this year by the FDA of Noven’s Miami facility.

The lifting of the Warning Letter is the result of a comprehensive remediation program that not only addressed the issues raised by FDA in the 2016 Warning Letter, but included the assessment and remediation of all aspects of Noven’s quality systems to ensure alignment with current Good Manufacturing Practices.

“For more than two years now, we have been focused on creating a robust and sustainable quality program based on a culture of quality, accountability across the entire organization and the continuous improvement of our people, processes and products,” said Jeff Mihm, Noven chief executive officer. 

“Noven’s enhanced quality program provides a strong foundation for our plans to bring new transdermal products to patients in the United States and abroad,” Mr. Mihm added. Noven currently manufactures and sells three transdermal products in the United States, and together with its Japanese parent company, Hisamitsu Pharmaceutical Co., Inc., has several new transdermal products in mid- to late-stage development.

(Source: Noven Pharmaceuticals, Inc.)

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE